Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "humanities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"700 - The arts; fine & decorative arts"
Showing
1
-
18
of
18
Search:
'"humanities"'
,
query time: 0.07s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have r...
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ adverse effects...
”
Read Now
2
Pharmacoeconomic review report: Sarilumab (Kevzara)
Published 2017
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
4
Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
5
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
6
Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ therapeutic use...
”
Read Now
7
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
8
Sarilumab (Kevzara)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ therapeutic use...
”
Read Now
9
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
10
Patient group input submissions: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ therapeutic use...
”
Read Now
11
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
12
Patient group input submissions: Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or photothe...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ therapeutic use...
”
Read Now
13
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
14
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
15
Ustekinumab (Stelara) injection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... or in combination with methotrexate. Ustekinumab is a fully
human
IgG1 kappa monoclonal antibody that binds...
”
Read Now
16
Ustekinumab (Stelara) injection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... or in combination with methotrexate. Ustekinumab is a fully
human
IgG1 kappa monoclonal antibody that binds...
”
Read Now
17
Canakinumab (Ilaris)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... mortality rate that may reach 20%. Canakinumab is a fully
human
monoclonal antibody that selectively binds...
”
Read Now
18
Canakinumab (Ilaris)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... mortality rate that may reach 20%. Canakinumab is a fully
human
monoclonal antibody that selectively binds...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 700 - The arts; fine & decorative arts
Year of Publication
From:
To:
Classification
700 - The arts; fine & decorative arts
140 - Specific philosophical schools
14
330 - Economics
6
610 - Medicine & health
4
Language
English
18
Collection
National Center for Biotechnology Information
18
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
3
Multiple Sclerosis Society of Canada
1
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22700+-+The+arts%3B+fine+%26+decorative+arts%22&lookfor=%22humanities%22&type=AllFields
Send by Email
×
Loading...